CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 12 enrolled
Drug / intervention
200 mcg LSD +2 moredrug
Likely dose
200 mcg LSDfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00920387
NCT00920387Phase 2Completed
CompareCT.gov

LSD-assisted Psychotherapy in Persons Suffering From Anxiety Associated With Advanced-stage Life Threatening Diseases. A Phase-II, Double-blind, Placebo-controlled Dose-response Pilot Study

Multidisciplinary Association for Psychedelic Studies·interventional·Posted Jun 15, 2009·Updated Jul 12, 2023

In Brief

A Phase 2 clinical trial evaluating 200 mcg LSD, 20 mcg LSD, and 1 other intervention for Anxiety. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This study will find out whether psychotherapy combined with lysergic acid diethylamide (LSD) is safe and is helpful in people who are anxious because they have a potentially fatal disease. The study will measure anxiety and quality of life before and after people have two sessions with either full or active placebo dose of LSD. They expect LSD-assisted psychotherapy to reduce anxiety and improve quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety
CountriesSwitzerland
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 15, 2009
Enrollment StartFeb 1, 2008
Primary CompletionApr 14, 2011
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 17.0 years ago

Interventions

200 mcg LSDdrug

Administering 200 mcg LSD orally once at the start of each of two day-long psychotherapy session

20 mcg LSDdrug

Administer 20 mcg LSD orally once at the start of each of two day-long psychotherapy session

Therapybehavioral

Therapy provided by male and female co-therapists